Can Expression of Apoptosis Genes, bcl-2 and bax, Predict Survival and Responsiveness to Chemotherapy in Node-Negative Breast Cancer Patients?

This publication has 33 references indexed in Scilit:

• Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients2 2
  Journal of the American College of Surgeons, 2000
• Meta-Analysis of Sentinel Lymph Node Biopsy in Breast Cancer
  Journal of Surgical Research, 1999
• Stereotactic Core Biopsy Reduces the Reexcision Rate and the Cost of Mammographically Detected Cancer
  Journal of Surgical Research, 1998
• Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis
  International Journal of Cancer, 1996
• Expression of the bcl‐2 gene family in normal and malignant breast tissue: Low bax‐α expression in tumor cells correlates with resistance towards apoptosis
  International Journal of Cancer, 1995
• Apoptosis. Its significance in cancer and cancer Therapy
  Cancer, 1994
• Tenascin Staining Positivity and the Survival of Patients with Invasive Breast Carcinoma
  Journal of Surgical Research, 1993
• Evaluating the Potential Usefulness of New Prognostic and Predictive Indicators on Node-Negative Breast Cancer Patients
  JNCI Journal of the National Cancer Institute, 1993
• Expression in Non-Hodgkin's Lymphoma of thebcl-2 Protein Associated with the t(14;18) Chromosomal Translocation
  New England Journal of Medicine, 1988
• Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.
  Proceedings of the National Academy of Sciences, 1986